ScholarLens Back to search
2007•The Pediatric Infectious Disease JournalRequires access

SUCCESSFUL MEDICAL TREATMENT OF CUTANEOUS ASPERGILLOSIS IN A PREMATURE INFANT USING LIPOSOMAL AMPHOTERICIN B, VORICONAZOLE AND MICAFUNGIN

Roberto Parulan Santos, Pablo J. Sánchez, Asunción Mejías, Daniel K. Benjamin, Thomas J. Walsh, Sanjay Valabh Patel, Hasan S. Jafri

Open publisher page 73 citations

Abstract

Treatment options for primary cutaneous aspergillosis in neonates are limited by the lack of pharmacokinetic and safety data of newer antifungal agents that are effective against Aspergillus spp. We report the successful treatment of cutaneous aspergillosis in an extremely low-birth-weight preterm infant with liposomal amphotericin B, voriconazole and micafungin, and provide pharmacokinetic profiles for voriconazole and micafungin.

About this research paper

What this paper is about

Treatment options for primary cutaneous aspergillosis in neonates are limited by the lack of pharmacokinetic and safety data of newer antifungal agents that are effective against Aspergillus spp. We report the successful treatment of cutaneous aspergillosis in an extremely low-birth-weight preterm infant with liposomal amphotericin B, voriconazole and micafungin, and provide pharmacokinetic profiles for voriconazole and micafungin.

Why it matters

OpenAlex reports 73 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Treatment options for primary cutaneous aspergillosis in neonates are limited by the lack of pharmacokinetic and safety data of newer antifungal agents that are effective against Aspergillus spp. We report the successful treatment of cutaneous aspergillosis in an extremely low-birth-weight preterm infant with liposomal amphotericin B, voriconazole and micafungin, and provide pharmacokinetic profiles for voriconazole and micafungin.

Key concepts: Micafungin, Voriconazole, Medicine, Aspergillosis, Amphotericin B, Pharmacokinetics, Antifungal, Mycosis

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
SUCCESSFUL MEDICAL TREATMENT OF CUTANEOUS ASPERGILLOSIS IN A PREMATURE INFANT USING LIPOSOMAL AMPHOTERICIN B, VORICONAZOLE AND MICAFUNGIN — Research Paper | ScholarLens